Literature DB >> 24167318

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Rui-Zhe Phang1, Felix Chang Tay, Sal-Lee Goh, Cia-Hin Lau, Haibao Zhu, Wee-Kiat Tan, Qingle Liang, Can Chen, Shouhui Du, Zhendong Li, Johan Chin-Kang Tay, Chunxiao Wu, Jieming Zeng, Weimin Fan, Han Chong Toh, Shu Wang.   

Abstract

Integrative gene transfer using retroviruses to express reprogramming factors displays high efficiency in generating induced pluripotent stem cells (iPSCs), but the value of the method is limited because of the concern over mutagenesis associated with random insertion of transgenes. Site-specific integration into a preselected locus by engineered zinc-finger nuclease (ZFN) technology provides a potential way to overcome the problem. Here, we report the successful reprogramming of human fibroblasts into a state of pluripotency by baculoviral transduction-mediated, site-specific integration of OKSM (Oct3/4, Klf4, Sox2, and c-myc) transcription factor genes into the AAVS1 locus in human chromosome 19. Two nonintegrative baculoviral vectors were used for cotransduction, one expressing ZFNs and another as a donor vector encoding the four transcription factors. iPSC colonies were obtained at a high efficiency of 12% (the mean value of eight individual experiments). All characterized iPSC clones carried the transgenic cassette only at the ZFN-specified AAVS1 locus. We further demonstrated that when the donor cassette was flanked by heterospecific loxP sequences, the reprogramming genes in iPSCs could be replaced by another transgene using a baculoviral vector-based Cre recombinase-mediated cassette exchange system, thereby producing iPSCs free of exogenous reprogramming factors. Although the use of nonintegrating methods to generate iPSCs is rapidly becoming a standard approach, methods based on site-specific integration of reprogramming factor genes as reported here hold the potential for efficient generation of genetically amenable iPSCs suitable for future gene therapy applications.

Entities:  

Keywords:  Cre-loxP system; Gene delivery systems in vivo or in vitro; Gene expression; Induced pluripotent stem cells

Mesh:

Substances:

Year:  2013        PMID: 24167318      PMCID: PMC3841088          DOI: 10.5966/sctm.2013-0043

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  33 in total

1.  Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.

Authors:  Y Zhao; D H Lam; J Yang; J Lin; C K Tham; W H Ng; S Wang
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

2.  Generation of iPS cells using a BacMam multigene expression system.

Authors:  Yoko Takata; Hiroe Kishine; Takefumi Sone; Taichi Andoh; Masami Nozaki; Michael Poderycki; Jonathan D Chesnut; Fumio Imamoto
Journal:  Cell Struct Funct       Date:  2011-10-06       Impact factor: 2.212

3.  Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model.

Authors:  Jing Yang; Dang Hoang Lam; Sally Sallee Goh; Esther Xingwei Lee; Ying Zhao; Felix Chang Tay; Can Chen; Shouhui Du; Ghayathri Balasundaram; Mohammad Shahbazi; Chee Kian Tham; Wai Hoe Ng; Han Chong Toh; Shu Wang
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

4.  Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma.

Authors:  Xiao Ying Bak; Dang Hoang Lam; Jingye Yang; Kai Ye; Esther Lee Xing Wei; Sai Kiang Lim; Shu Wang
Journal:  Hum Gene Ther       Date:  2011-05-16       Impact factor: 5.695

Review 5.  Pluripotent stem cell-based cancer therapy: promise and challenges.

Authors:  Saul J Sharkis; Richard J Jones; Curt Civin; Yoon-Young Jang
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

Review 6.  Concise review: putting a finger on stem cell biology: zinc finger nuclease-driven targeted genetic editing in human pluripotent stem cells.

Authors:  Joseph Collin; Majlinda Lako
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

7.  Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases.

Authors:  Yuning Lei; Chi-Lin Lee; Kye-Il Joo; Jonathan Zarzar; Yarong Liu; Bingbing Dai; Victoria Fox; Pin Wang
Journal:  Mol Ther       Date:  2011-02-15       Impact factor: 11.454

8.  Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA.

Authors:  Marisa Karow; Christopher L Chavez; Alfonso P Farruggio; Jonathan M Geisinger; Annahita Keravala; W Edward Jung; Feng Lan; Joseph C Wu; Yanru Chen-Tsai; Michele P Calos
Journal:  Stem Cells       Date:  2011-11       Impact factor: 6.277

Review 9.  The promise of induced pluripotent stem cells in research and therapy.

Authors:  Daisy A Robinton; George Q Daley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 10.  Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.

Authors:  Chi-Yuan Chen; Chin-Yu Lin; Guan-Yu Chen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2011-04-28       Impact factor: 14.227

View more
  8 in total

1.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

2.  The potential of stem cell-based therapy for retinal repair.

Authors:  Honghua Yu; Lin Cheng; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2014-06-01       Impact factor: 5.135

3.  Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.

Authors:  Yovita Ida Purwanti; Can Chen; Dang Hoang Lam; Chunxiao Wu; Jieming Zeng; Weimin Fan; Shu Wang
Journal:  Stem Cells Transl Med       Date:  2014-06-27       Impact factor: 6.940

4.  Enhancing Cystic Fibrosis Immune Regulation.

Authors:  Anna M van Heeckeren; Morgan T Sutton; David R Fletcher; Craig A Hodges; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

5.  Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system.

Authors:  Cia-Hin Lau; Haibao Zhu; Johan Chin-Kang Tay; Zhendong Li; Felix Chang Tay; Can Chen; Wee-Kiat Tan; Shouhui Du; Vic-Ki Sia; Rui-Zhe Phang; Shin-Yi Tang; Chiyun Yang; Zhixia Chi; Chieh-Ching Liang; Er Ning; Shu Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2014-10-29       Impact factor: 6.698

6.  Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis.

Authors:  Wei Xia Ang; Zhendong Li; Zhixia Chi; Shou-Hui Du; Can Chen; Johan C K Tay; Han Chong Toh; John E Connolly; Xue Hu Xu; Shu Wang
Journal:  Oncotarget       Date:  2017-02-21

7.  Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.

Authors:  Shin Yi Tang; Shijun Zha; Zhicheng Du; Jieming Zeng; Detu Zhu; Yumei Luo; Shu Wang
Journal:  Stem Cell Res Ther       Date:  2021-11-21       Impact factor: 6.832

8.  An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool.

Authors:  Nasir Javaid; Sangdun Choi
Journal:  Stem Cells Int       Date:  2022-09-22       Impact factor: 5.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.